Wells Fargo & Company Sonendo, Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.75 - $1.4 $45 - $85	61 Added 22.02%	338 $0
Q2 2023 Aug 15, 2023	BUY	$1.06 - $2.01 $20 - $38	19 Added 7.36%	277 $0
Q1 2023 May 12, 2023	BUY	$1.53 - $2.71 $6 - $10	4 Added 1.57%	258 $0
Q4 2022 Feb 13, 2023	BUY	$1.11 - $2.9 $176 - $461	159 Added 167.37%	254 $0
Q3 2022 Nov 14, 2022	BUY	$0.91 - $2.09 $38 - $87	42 Added 79.25%	95 $0
Q2 2022 Aug 12, 2022	BUY	$1.72 - $3.73 $6 - $14	4 Added 8.16%	53 $0
Q1 2022 May 16, 2022	SELL	$3.12 - $8.17 $66,817 - $174,968	-21,416 Reduced 99.77%	49 $0
Q4 2021 Feb 14, 2022	BUY	$5.72 - $11.56 $122,779 - $248,135	21,465 New	21,465 $123,000

7.78M

Ticker SONX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,661,200
Market Cap $105M
Description
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company a...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.